Clinical trials: Locally Advanced Cervical Carcinoma
- Condition Locally Advanced Cervical Carcinoma
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Locally Advanced Cervical Cancer
Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)
This is a randomized, multi-center, double-blind, placebo-controlled, global, Phase III study to determine the efficacy and safety of durvalumab + Chemoradiotherapy versus Chemoradiotherapy alone as treatment in Women With…
- Trial name
- CALLA (NCT03830866)
- Testing
- Durvalumab, Cisplatin, Carboplatin
- Where
- 117 sites in United States, Brazil and 13 more
- Volunteers
- 770 people
- Sponsor
- AstraZeneca